Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Natural Product Reports is Scopus-indexed (Q1, CiteScore 21.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Royal Society of Chemistry.
Checked against the index lists dated .
ISSN 0265-0568Verify ISSN ↗1460-4752Verify ISSN ↗
Publisher: Royal Society of Chemistry
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Drug Discovery | 4 / 161 | 97th | Q1 |
| Organic Chemistry | 6 / 215 | 97th | Q1 |
| Biochemistry | 15 / 448 | 96th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present, best quartile Q1, CiteScore 21.2.
Natural Product Reports is Q1 in Drug Discovery (rank 4 of 161), Q1 in Organic Chemistry (rank 6 of 215) and Q1 in Biochemistry (rank 15 of 448), by CiteScore 2025.
Natural Product Reports is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 21.2, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.187, quartile Q1, with an H-index of 225.
Natural Product Reports is published by Royal Society of Chemistry. Its print ISSN is 0265-0568 and its online ISSN is 1460-4752.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Natural Product Reports has an h-index of 250 and a 2-year mean of 8.68 citations per paper (OpenAlex). Its Scopus CiteScore is 21.2, quartile Q1. On 2-year citations it ranks #6 of 159 Scopus journals in Drug Discovery.
Natural Product Reports published 133 papers in 2025; its busiest recent year was 2018 with 136. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (26.2%), United States (16.5%) and Germany (10.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.